Compounds > coformycin

Page last updated: 2024-08-22

coformycin and Neoplasms

coformycin has been researched along with Neoplasms in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adamson, RH; Chassin, MM; Harrap, KR; Jackman, AL; Johns, DG; Paine, RM; Smyth, JF	1
Bruno, S; Macdonald, JS; Marsoni, S; Poster, D	1
Harrap, KR; Paine, RM; Smyth, JF	1
Calabresi, P; Crabtree, GW; Cummings, FJ; Parks, RE; Spremulli, EN; Wiemann, MC	1
Berger, NA; Lazarus, HM	1
Marsoni, S; O'Dwyer, PJ; Spiers, AS	1
Hubbell, HR; Lee, C; Pequignot, EC; Suhadolnik, RJ; Willis, DH	1

Reviews

1 review(s) available for coformycin and Neoplasms

Article	Year
Chemotherapy of malignant disease: an update. Comprehensive therapy, 1988, Volume: 14, Issue:5 Topics: Amsacrine; Antineoplastic Agents; Cisplatin; Coformycin; Etoposide; Female; Humans; Ifosfamide; Male; Mitoxantrone; Neoplasms; Pentostatin; Pregnancy	1988

Other Studies

6 other study(ies) available for coformycin and Neoplasms

Article	Year
The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin. Cancer chemotherapy and pharmacology, 1980, Volume: 5, Issue:2 Topics: Adenosine Deaminase Inhibitors; Adult; Aged; Animals; Coformycin; Dogs; Female; Humans; Kinetics; Leukemia, Lymphoid; Lymphocytes; Male; Middle Aged; Nausea; Neoplasms; Nucleoside Deaminases; Pentostatin; Ribonucleosides; Uric Acid	1980
Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1982, Volume: 80 Topics: Adenosine Deaminase Inhibitors; Aminoacridines; Amsacrine; Anthracenes; Antineoplastic Agents; Coformycin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia; Mitoxantrone; Neoplasms; Nucleoside Deaminases; Pentostatin; Ribonucleosides	1982
Biochemical consequences of treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin. Advances in experimental medicine and biology, 1979, Volume: 122B Topics: Adolescent; Adult; Animals; Coformycin; Drug Evaluation; Erythrocytes; Humans; Lectins; Lymphocyte Activation; Lymphocytes; Male; Mice; Middle Aged; Neoplasms; Organ Size; Pentostatin; Ribonucleosides; Ribonucleotides; Spleen	1979
Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin. Clinical pharmacology and therapeutics, 1988, Volume: 44, Issue:5 Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Adult; Aged; Antineoplastic Agents; Coformycin; Female; Humans; Immunity; Immunosuppressive Agents; Male; Middle Aged; Neoplasms; Nucleoside Deaminases; Pentostatin; Ribonucleosides	1988
Association of severe and fatal infections and treatment with pentostatin. Cancer treatment reports, 1986, Volume: 70, Issue:9 Topics: Adolescent; Adult; Aged; Bacterial Infections; Child; Coformycin; Drug Evaluation; Female; Herpes Zoster; Humans; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Neoplasms; Pentostatin; Ribonucleosides	1986
Differential antiproliferative actions of 2',5' oligo A trimer core and its cordycepin analogue on human tumor cells. International journal of cancer, 1985, Sep-15, Volume: 36, Issue:3 Topics: Adenine Nucleotides; Adenosine; Cell Division; Cell Line; Coformycin; Culture Techniques; Dose-Response Relationship, Drug; Drug Resistance; Humans; Neoplasms; Oligodeoxyribonucleotides; Oligonucleotides; Oligoribonucleotides; Pentostatin	1985